Premium
Vascularization and cellular isolation potential of a novel electrospun cell delivery vehicle
Author(s) -
Krishnan Laxminarayanan,
Touroo Jeremy,
Reed Robert,
Boland Eugene,
Hoying James B.,
Williams Stuart K.
Publication year - 2014
Publication title -
journal of biomedical materials research part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.849
H-Index - 150
eISSN - 1552-4965
pISSN - 1549-3296
DOI - 10.1002/jbm.a.34900
Subject(s) - materials science , biomedical engineering , electrospinning , transplantation , membrane , tissue engineering , porosity , scaffold , nanotechnology , composite material , polymer , chemistry , surgery , medicine , biochemistry
A clinical need exists for a cell delivery device that supports long‐term cell viability, cell retention within the device and retrieval of delivered cells if necessary. Previously, cell isolation devices have been based on hollow fiber membranes, porous polymer scaffolds, alginate systems, or micro‐machined membranes. We present the development and characterization of a novel dual porosity electrospun membrane based device, which supports cellular infiltration and vascularization of its outer porous layer and maintains cellular isolation within a lumen bounded by an inner low porosity layer. Electrospinning conditions were initially established to support electrospun fiber deposition onto nonconductive silicone surfaces. With these parameters established, devices for in vivo evaluations were produced using nylon as a nonconductive scaffold for deposition of dual porosity electrospun fibers. The outer porous layer supported the development of a penetrating microcirculation and the membrane supported the transfer of insulin from encapsulated sustained release pellets for 4 weeks. Viable cells implanted within the device could be identified after 2 weeks of implantation. Through the successful demonstration of survival and cellular isolation of human epithelial cells within the implanted devices and the ability to use the device to deliver insulin, we have established the utility of this device toward localized cell transplantation. The cell delivery device establishes a platform to test the feasibility of approaches to cell dose control and cell localization at the site of implantation in the clinical use of modified autologous or allogeneic cells. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 2208–2219, 2014.